Quick answers
- What is Procainamide Hci?
- Procainamide Hci is a brand name of Procainamide hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Procainamide Hci product in 1 strength and form.
- Who makes Procainamide Hci?
- Hospira holds the FDA application for Procainamide Hci (ANDA089069, approved February 12, 1986).
- Is there a generic or store brand of Procainamide Hci?
- Yes. The FDA NDC Directory lists 6 other products with the same active ingredients, strength and form as a Procainamide Hci product, 6 of them generic. Ask your pharmacist whether one is right for you.
- Has Procainamide Hci been recalled?
- No recall linked to Procainamide Hci products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Procainamide Hci is
Each Procainamide Hci product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Procainamide hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| procainamide hydrochloride 100 mg/mL injection, solution (intramuscular, intravenous) | Procainamide Hci | 6 products, 5 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Procainamide hydrochloride →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA089069 | Hospira | February 12, 1986 | 1 |
Companies that list Procainamide Hci
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Procainamide Hci products.
Recalls
No recall linked to Procainamide Hci products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.